2.57
Finanzdaten der Edesa Biotech Inc-Aktie (EDSA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
43.03%
3.9579
|
2.7671 | 1.1247 | 1.2255 | 0.9391 |
| Operating Income/Loss |
28.45%
-5.5195
|
-4.297 | -2.3414 | -2.4702 | -1.9037 |
| Nonoperating Income/Loss |
40.87%
0.1119
|
0.0795 | 0.0937 | 0.2419 | 0.1543 |
| Income/Loss From Continuing Operations Before Tax |
28.22%
-5.4076
|
-4.2175 | -2.2477 | -2.2284 | -1.7495 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.0008 | - | - | - |
| Net Income/Loss |
28.19%
-5.4076
|
-4.2183 | -2.2477 | -2.2284 | -1.7495 |
| Basic Average Shares |
5.46%
9.0075
|
8.5411 | 7.9725 | 0.4594 | 7.0227 |
| Basic Earnings Per Share |
22.45%
-0.60
|
-0.49 | -0.28 | -0.32 | -0.25 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):